Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
Koie T, Ohyama C, Hosogoe S, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Mori K. Koie T, et al. Among authors: hosogoe s. Int Urol Nephrol. 2015 Sep;47(9):1509-14. doi: 10.1007/s11255-015-1048-3. Epub 2015 Jul 7. Int Urol Nephrol. 2015. PMID: 26149637
Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy.
Koie T, Ohyama C, Hatakeyama S, Imai A, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Hosogoe S, Yamamoto H, Kitayama M, Hirota K. Koie T, et al. Among authors: hosogoe s. Int J Clin Oncol. 2016 Apr;21(2):379-383. doi: 10.1007/s10147-015-0880-x. Epub 2015 Jul 30. Int J Clin Oncol. 2016. PMID: 26223693
Renal Function Outcomes and Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer [corrected].
Hatakeyama S, Koie T, Narita T, Hosogoe S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C. Hatakeyama S, et al. Among authors: hosogoe s. PLoS One. 2016 Feb 22;11(2):e0149544. doi: 10.1371/journal.pone.0149544. eCollection 2016. PLoS One. 2016. PMID: 26901860 Free PMC article.
Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery.
Sato T, Hatakeyama S, Okamoto T, Yamamoto H, Hosogoe S, Tobisawa Y, Yoneyama T, Hashiba E, Yoneyama T, Hashimoto Y, Koie T, Hirota K, Ohyama C. Sato T, et al. Among authors: hosogoe s. PLoS One. 2016 May 4;11(5):e0153961. doi: 10.1371/journal.pone.0153961. eCollection 2016. PLoS One. 2016. PMID: 27145178 Free PMC article. Clinical Trial.
Safety and Effectiveness of Marginal Donor in Living Kidney Transplantation.
Oikawa M, Hatakeyama S, Narita T, Yamamoto H, Hosogoe S, Imai A, Yoneyama T, Hashimoto Y, Koie T, Fujita T, Murakami R, Saitoh H, Funyu T, Narumi S, Ohyama C. Oikawa M, et al. Among authors: hosogoe s. Transplant Proc. 2016 Apr;48(3):701-5. doi: 10.1016/j.transproceed.2015.09.067. Transplant Proc. 2016. PMID: 27234717
Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.
Kusaka A, Hatakeyama S, Hosogoe S, Hamano I, Iwamura H, Fujita N, Fukushi K, Narita T, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Ohyama C. Kusaka A, et al. Among authors: hosogoe s. Med Oncol. 2017 May;34(5):90. doi: 10.1007/s12032-017-0955-9. Epub 2017 Apr 10. Med Oncol. 2017. PMID: 28397105
Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma.
Hosogoe S, Hatakeyama S, Kusaka A, Hamano I, Tanaka Y, Hagiwara K, Hirai H, Morohashi S, Kijima H, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ohyama C. Hosogoe S, et al. Oncotarget. 2017 Jul 25;8(30):49749-49756. doi: 10.18632/oncotarget.17930. Oncotarget. 2017. PMID: 28572534 Free PMC article.
23 results